Despite very scarce evidence, the current research on hydrogen in the treatment of cerebral ischemia with reperfusion seems interesting and promising for the future as a neuroprotective molecule and preventing the deposition of various amyloid plaques and dysfunctional tau protein in the form of neurofibrillary tangles (Figure 1). This evidence concerns the gene MAPT and brain ischemia.